Literature DB >> 11743345

The ultimate challenge of cloacal exstrophy.

Justine M Schober1, Polly A Carmichael, Melissa Hines, Philip G Ransley.   

Abstract

PURPOSE: Our review addresses the various system abnormalities associated with cloacal exstrophy and revisits the question of gender assignment. Gender assignment decisions and psychological aspects of gender issues have become the "ultimate challenge." Exploration of gender identity, gender role behavior and sexual orientation has just begun.
MATERIALS AND METHODS: A comprehensive literature review was performed with all world literature regarding the current management of cloacal exstrophy. Research focused on management principles, outcomes and documentation of concurrent anomalies. We also describe original research evaluating gender identity in our own series of patients raised as girls to illustrate the challenge of treatment and augment the available literature, which is scant.
RESULTS: Abnormalities of the vertebral column ranged from hemivertebra to myelomeningocele. With magnetic resonance imaging, the incidence of spinal dysraphism approached 100% and cord tethering was also more frequently recognized. For children with the short bowel syndrome, advances in antibiotic usage, and parenteral and enteral nutrition have increased the survival rate and reduced morbidity. A neurological component has been recognized for bladder function, bladder neck continence, lower extremity function and erectile capacity. Mitrofanoff-type reconstruction with bladder neck closure and continent catheterizable stoma dramatically increased continence. Diminutive or absent penis has been documented in 30% of males, and no documentation of paternity exists. The majority of females have bicornuate uterus. However, ovaries and tubes were generally normal. No reports of proven fertility exist.
CONCLUSIONS: The strategy and timing of surgery relating to gender assignment remain controversial. A desperate need exists for research focusing on gender development and quality of life. Until that time, a cautious watchful approach may be most appropriate as our patients with cloacal exstrophy mature into adulthood.

Entities:  

Mesh:

Year:  2002        PMID: 11743345

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth.

Authors:  William G Reiner; John P Gearhart
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

2.  Challenges in pediatric urologic practice: a lifelong view.

Authors:  John S Wiener; Nina Huck; Anne-Sophie Blais; Mandy Rickard; Armando Lorenzo; Heather N McCaffrey Di Carlo; Margaret G Mueller; Raimund Stein
Journal:  World J Urol       Date:  2020-04-23       Impact factor: 4.226

3.  Gender identity and sex-of-rearing in children with disorders of sexual differentiation.

Authors:  William G Reiner
Journal:  J Pediatr Endocrinol Metab       Date:  2005-06       Impact factor: 1.634

Review 4.  The Genomic Architecture of Bladder Exstrophy Epispadias Complex.

Authors:  Glenda M Beaman; Raimondo M Cervellione; David Keene; Heiko Reutter; William G Newman
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

Review 5.  Modern management of the exstrophy-epispadias complex.

Authors:  Brian M Inouye; Ali Tourchi; Heather N Di Carlo; Ezekiel E Young; John P Gearhart
Journal:  Surg Res Pract       Date:  2014-01-05

6.  Should CAH in Females Be Classified as DSD?

Authors:  Ricardo González; Barbara M Ludwikowski
Journal:  Front Pediatr       Date:  2016-05-13       Impact factor: 3.418

7.  The current profile of persistent cloaca and cloacal exstrophy in Japan: the results of a nationwide survey in 2014 and a review of the literature.

Authors:  Masayuki Kubota
Journal:  Pediatr Surg Int       Date:  2017-01-05       Impact factor: 1.827

Review 8.  The exstrophy-epispadias complex.

Authors:  Anne-Karoline Ebert; Heiko Reutter; Michael Ludwig; Wolfgang H Rösch
Journal:  Orphanet J Rare Dis       Date:  2009-10-30       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.